Comparison of efficacy and tolerability between transdermal fentanyl and oral oxycodone in patients with cancer pai
Phase 3
- Conditions
- Cancer pain
- Registration Number
- JPRN-C000000339
- Lead Sponsor
- Department of anesthesia, Kyoto University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
(1) patients with severe hepatic, renal, cardiocascular or pulmonary disease (2) patients with past history of heart or psychiatric disease (3) preganat or nursing patients and patients who may be pregnant (4) unconsciousness patient who cannot communicate (5) Patients who have contraindication to oral oxycodone and transdermal fentanyl (6) Patients taking fentanyl, extended-release morphine or opioid agonist-antagonists (7) A daily dose of oxycodone is not constant after agreement (8) Patients with a medical problem with this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of a conversion ratio of oral oxycodone to transdermal fentanyl
- Secondary Outcome Measures
Name Time Method Comparison of side effects between oral oxycodone and transdermal fentanyl